Shigeo Hanada

1.4k total citations · 1 hit paper
49 papers, 915 citations indexed

About

Shigeo Hanada is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Shigeo Hanada has authored 49 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 18 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Shigeo Hanada's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Pneumonia and Respiratory Infections (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Shigeo Hanada is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Pneumonia and Respiratory Infections (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Shigeo Hanada collaborates with scholars based in Japan, United States and Australia. Shigeo Hanada's co-authors include Jane C. Deng, Mina Pirzadeh, Kazuma Kishi, Hironori Uruga, Kimiko Ubukata, Hisashi Takaya, Nasa Morokawa, Miyuki Morozumi, Atsushi Miyamoto and Satoshi Iwata and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Shigeo Hanada

46 papers receiving 891 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia

2018 347 citations Shigeo Hanada, Mina Pirzadeh et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Shigeo Hanada

Since Specialization

Citations

This map shows the geographic impact of Shigeo Hanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeo Hanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeo Hanada more than expected).

Fields of papers citing papers by Shigeo Hanada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeo Hanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeo Hanada. The network helps show where Shigeo Hanada may publish in the future.

Co-authorship network of co-authors of Shigeo Hanada

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeo Hanada. A scholar is included among the top collaborators of Shigeo Hanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeo Hanada. Shigeo Hanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational study 2025 ·European Journal of Clinical Microbiology & Infectious Diseases ·Shigeo Hanada, Takeaki Wajima, (unknown), Miyuki Morozumi, Yukio Sato, Junichi Sasaki, Satoshi Iwata, Kimiko Ubukata	0
2	Clinical manifestations and biomarkers to predict mortality risk in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infections 2024 ·European Journal of Clinical Microbiology & Infectious Diseases ·Shigeo Hanada, Takeaki Wajima, (unknown), Miyuki Morozumi, (unknown), Satoshi Iwata, Kimiko Ubukata	2
3	Risk factors and pathogen characteristics associated with unfavorable outcomes among adults with pneumococcal meningitis in Japan, 2006 to 2016 2023 ·Journal of Infection and Chemotherapy ·Satoshi Iwata, Shigeo Hanada, (unknown), Miyuki Morozumi, Satoshi Kamei, Kimiko Ubukata	4
4	Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years 2021 ·Journal of Infection and Chemotherapy ·Shigeo Hanada, (unknown), Miyuki Morozumi, Satoshi Iwata, Seitaro Fujishima, Kimiko Ubukata	5
5	Safety of bronchoscopy in patients with malignant hematologic disorders 2020 ·BMC Pulmonary Medicine ·Hironori Uruga, (unknown), Aya Nishida, Naoyuki Uchida, Masanori Tsuji, (unknown), (unknown), Kazumasa Ogawa, (unknown), Shigeo Hanada, (unknown), Atsushi Miyamoto, Nasa Morokawa, Muneyoshi Kimura, Hideki Araoka, (unknown), Yuki Asano‐Mori, (unknown), Shuichi Taniguchi, Kazuma Kishi	2
6	Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report 2020 ·Respiratory Medicine Case Reports ·(unknown), Atsushi Miyamoto, Hiroshi Nakahama, (unknown), (unknown), Kazumasa Ogawa, (unknown), Shigeo Hanada, Nasa Morokawa, Atsuko Kurosaki, Takeshi Fujii, Eiko Hasegawa, Hisashi Takaya, Daiya Takai	3
7	Development of a CT image case database and content-based image retrieval system for non-cancerous respiratory diseases: Method and preliminary assessment 2019 ·Respiratory Investigation ·(unknown), Atsuko Kurosaki, (unknown), (unknown), Kazumasa Ogawa, Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Nasa Morokawa, Kazuma Kishi	6
8	Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report 2019 ·BMC Cancer ·(unknown), Atsushi Miyamoto, (unknown), (unknown), Yui Takahashi, Kazumasa Ogawa, (unknown), Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Nasa Morokawa, Kazuma Kishi	6
9	Treatment outcome of patients with unresectable stage III non-small cell lung cancer and interstitial pneumonia 2019 ·Respiratory Investigation ·Kazumasa Ogawa, Yui Takahashi, (unknown), Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Atsuko Kurosaki, Kazuma Kishi	2
10	Reduced area of the normal lung on high-resolution computed tomography predicts poor survival in patients with lung cancer and combined pulmonary fibrosis and emphysema 2018 ·Respiratory Investigation ·Atsushi Miyamoto, Atsuko Kurosaki, (unknown), Yui Takahashi, Kazumasa Ogawa, (unknown), Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Nasa Morokawa, Takeshi Fujii, Junichi Hoshino, Kazuma Kishi	5
11	OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia 2018 ·Respiratory Investigation ·Kazumasa Ogawa, (unknown), (unknown), Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Atsuko Kurosaki, Kazuma Kishi	13
12	Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia breakdown → 2018 ·Frontiers in Immunology ·Shigeo Hanada, Mina Pirzadeh, (unknown), Jane C. Deng	347
13	Antemortem diagnosis of pulmonary tumor thrombotic microangiopathy in a patient with recurrent breast cancer: a case report 2016 ·BMC Cancer ·Yui Takahashi, Hironori Uruga, Takeshi Fujii, (unknown), Shigeo Hanada, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Atsuko Kurosaki, Kazuma Kishi	11
14	Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients 2016 ·Internal Medicine ·(unknown), Atsushi Miyamoto, Daisuke Kato, (unknown), Kazumasa Ogawa, (unknown), (unknown), Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Nasa Morokawa, Kazuma Kishi	15
15	Multiplex real-time polymerase chain reaction is useful in diagnosing pathogens causing community-acquired pneumonia including atypical bacteria and viruses 2014 ·European Respiratory Journal ·Yutaka Yoshii, Kenichiro Shimizu, Miyuki Morozumi, Naoko Chiba, Kimiko Ubukata, Hironori Uruga, Shigeo Hanada, Kazuma Kishi, Hiroshi Wakui, Shunsuke Minagawa, Jun Kojima, Hiromichi Hara, Takanori Numata, Makoto Kawaishi, Jun Araya, Yumi Kaneko, Katsutoshi Nakayama, Kazuyoshi Kuwano	1
16	Pulmonary tumor thrombotic microangiopathy: A clinical analysis of 30 autopsy cases 2013 ·European Respiratory Journal ·Hironori Uruga, Takeshi Fujii, Atsuko Kurosaki, (unknown), Kazumasa Ogawa, Masayuki Ishibashi, Toshitaka Sato, (unknown), Shigeo Hanada, (unknown), Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Sakae Homma, Kazuma Kishi	39
17	Hereditary Hemorrhagic Telangiectasia with Pulmonary Arteriovenous Malformations and Embolic Strokes Treated Successfully with Video-assisted Thoracoscopic Resection 2013 ·Internal Medicine ·Shintaro Akiyama, Shigeo Hanada, Hironori Uruga, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Atsuko Kurosaki, Takeshi Fujii, Tadasu Kohno, Kazuma Kishi	10
18	Diagnostic efficacy of CT-guided transthoracic needle biopsy and fine needle aspiration in cases of pulmonary infectious disease 2012 ·Japanese Journal of Radiology ·Hironori Uruga, Hisashi Takaya, Shigeo Hanada, (unknown), Atsushi Miyamoto, Nasa Morokawa, Atsuko Kurosaki, Takeshi Fujii, Kazuma Kishi	8
19	[A case of pulmonary tumor thrombotic microangiopathy caused by carcinoma (salivary duct carcinoma) ex pleomorphic adenoma]. 2010 ·PubMed ·Hironori Uruga, Takeshi Fujii, Atsuko Kurosaki, Shigeo Hanada, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Kazuma Kishi	5
20	[Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome]. 1992 ·PubMed ·(unknown), Atae Utsunomiya, (unknown), Shigeo Hanada, (unknown), (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact